BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Information Letter on Keppra®: Changed dose recommendations

2010.02.01

Active substance: levetiracetam

Changed dose recommendations for use in children and adults are valid.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 1MB, File is accessible